Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic Veno-occlusive Disease in Children With Nephroblastoma or Acute Lymphoblastic Leukemia

NCT04168788 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT04168788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04168788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic Veno-occlusive Disease in Children With Nephroblastoma or Acute Lymphoblastic Leukemia
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2020
Completion date
July 7, 2025
Enrollment
85 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, hepatic veno-occlusive disease, nephroblastoma